Bristol-Myers Sets $160 Million Tax Reserve for Transfer Pricing
Bristol-Myers Squibb Increases Tax Reserves Amid IRS Transfer Pricing Dispute
Issue: Bristol-Myers Squibb (BMS) is contesting several IRS proposed adjustments related to transfer pricing and other tax matters for the 2008–2012 tax years. The dispute has been under appeal since 2022, reflecting long-standing scrutiny of multinational pharmaceutical companies’ intercompany pricing.
Present Result:
BMS set aside $160 million in additional tax reserves in Q3 2025 for these transfer pricing matters.
The company indicated that over the next 12 months, it may need to reduce unrecognized tax benefits by $260–300 million due to settlements of certain audits or related events.
No detailed IRS claim amounts were disclosed.
This proactive reserving contrasts with many taxpayers, who either underestimate transfer pricing exposure or fail to set aside sufficient reserves.
To-Dos / Expectations / Next Steps:
Strong documentation and early planning remain key to managing transfer pricing audit risk and potential penalties.
BMS will continue contesting the IRS adjustments through ongoing administrative and potential litigation channels.
Taxpayers with similar disputes should assess reserve adequacy carefully to avoid surprises in financial reporting.
Turn transfer pricing into a strategic advantage. From planning and documentation to dispute resolution, our team helps you optimize your global tax position while minimizing risk.
Scalar Conclusion: Recent Transfer Pricing Controversy Disputes , Decisions, and Agreements Global Transfer Pricing Enforcement: Multinationals Face Heightened Scrutiny Across the globe, tax authorities are stepping up enforcement of transfer pricing and cross-border transactions, targeting royalties, cost-sharing arrangements, and intercompany...
French International Tax Audits Brought in €5.2 Billion France Reports Major Spike in Recovered Taxes, Driven by Transfer Pricing Audits Issue:France’s tax authority (DGFiP) released new audit results showing a surge in recovered unpaid taxes, with transfer pricing and other...
IRS Settlement Indicates Continuation of M&A Carveout Fights Microsemi Cost-Sharing Case Settles, Leaving Key Platform Contribution Questions Unanswered Issue:The Microsemi v. Commissioner case was expected to clarify how taxpayers should determine platform contribution transaction (PCT) payments when newly acquired intangible...
3M Case Marks Pathway for Coca-Cola’s Transfer Pricing Victory Coca-Cola Sees Opportunity in 3M Transfer Pricing Win Coca-Cola is fighting an IRS transfer pricing adjustment that could total up to $18 billion in taxes and interest. The dispute focuses on...
Medtronic Seeks Panel Rehearing of Transfer Pricing Decision 1. Issue & What Was at Issue Issue:Medtronic is seeking a rehearing from the Eighth Circuit after the court sided with the IRS in a transfer pricing dispute regarding the valuation of...
Oracle Australia Wins Pause in $253 Million Royalty Tax Case 1. Issue & What Was at Issue Issue:Oracle Australia is disputing the Australian Taxation Office’s (ATO) position that certain intercompany license fees constitute royalties subject to withholding tax. What was...
